Skip to content
healthcare.dev

Metopirone

NDC 76336-455, Metyrapone, capsule, gelatin coated, from HRA Pharma Rare Diseases.

Product NDC
76336-455
Status
Listed
Labeler
HRA Pharma Rare Diseases
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA012911
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76336-455 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METYRAPONE250 mg/1

Pharmacologic classes

Adrenal Steroid Synthesis Inhibitor [EPC]; Adrenal Steroid Synthesis Inhibitors [MoA]

Package NDCNDC-11Package
76336-455-187633604551818 CAPSULE, GELATIN COATED in 1 BOTTLE (76336-455-18)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3a27d0ef-83a7-4e1c-9430-46a3326ee8d8

Use it

Look up 76336-455 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76336-455 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76336-455. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.